CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathway is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Prevention and Research Institute of Texas
Grant: RP2000103
Welch Foundation
Grant: 1-0025
HHS | NIH | National Cancer Institute
Grant: F31CA27167
NCI NIH HHS
Grant: F31 CA271675
NCI NIH HHS
Grant: P30 CA142543
National Institutes of Health
Grant: 5F31CA271675-02
The Molecular function of ecto 5' nucleotidase in fusion-negative rhabdomyosarcoma
FWCI
2.80
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals